Tag: pharmaceuticals
-
Synthetic Cannabidiol Shown to Reduce Seizures
A synthetic form of cannabidiol, or CBD, a derivative of cannabis, is shown in tests with lab rats to reduce the occurrence of seizures from epilepsy.
-
Gold Nanoparticles Boost Crispr Delivery
Cancer researchers designed a technique using gold nanoscale particles for safer delivery of edited gene therapies to blood-forming stem cells.
-
FDA Approves Rare Infant Disease Gene Therapy
The Food and Drug Administration today approved a treatment for spinal muscular atrophy in young children that replaces a faulty gene in motor neurons with a healthy one.
-
Viral Disease Biotech Joins ElevateBio, Gains $120M
A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies.
-
Pharmas Join Digital Clinical Trial Project
Four pharmaceutical companies are signing on to an initiative that promises to make clinical trials friendlier to patients and make better use of digital technology.
-
Start-Up to Use Stem Cells for Hearing Loss
A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear that causes hearing loss.
-
3-D Printed Scaffold Helps Grow Skull Bone
A Northwestern University bio-materials lab demonstrated the growth of new bone in skulls of lab animals on scaffolds made with three-dimensional printers.
-
Trial Shows Surgical Pain Managed Without Opioids
Results from a clinical trial show patients recovered from their hernia surgeries with non-opioid pain medications, and stayed off opioids for 15 days.
-
Company Helps Labs Build Gene, Cell Therapy Businesses
A new company formed offering full-scale facilities to develop cell and gene therapy products spun-off from academic research labs.
-
FDA Issues Final Biosimilar Guidance
The Food and Drug Administration issued its final guidance on regulating the interchangeability of so-called biosimilars with original biologic drugs.